Neladenoson bialanate (BAY1067197)
Sponsors
Bayer
Conditions
Heart Failure
Phase 2
A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction
CompletedNCT02992288
Start: 2017-02-22End: 2018-05-16Updated: 2019-04-23
A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction
CompletedNCT03098979
Start: 2017-05-10End: 2018-06-20Updated: 2019-07-23